Clinical trialNCT06716580RecruitingInterventional

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

SponsorDana-Farber Cancer InstituteEnrollment1,000EGFR Gene MutationLung Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research study is studying a new blood test to screen for Epidermal Growth Factor Receptor (EGFR) positive lung cancer in healthy individuals at risk for the disease and who cannot undergo regular lung cancer screening. The name of the test used in this research study is: -Circulating free DNA (cfDNA) Assay

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Narjust Florez, MD
Dana-Farber Cancer Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Daniel Costa, MD, PhD
Not, yet, recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Narjust Florez, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Lecia Sequist, MD, MPH
Not, yet, recruiting
Dana-Farber Cancer Institute at Steward St. Elizabeth'S
Brighton, Massachusetts, United States
Alys Malcolm, MD
Not, yet, recruiting
Dana-Farber Cancer Instiute Merrimack Valley
Methuen, Massachusetts, United States
Pedro Sanz-Altamira, MD
Not, yet, recruiting
Dana-Farber Cancer Institute South Shore
South Weymouth, Massachusetts, United States
Shail Maingi, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Apr 2025
Primary completion: 1 Sept 2027
Completion: 1 Sept 2030
Last update posted: 15 Jul 2026
Registered enrollment: 1,000
Registry id: NCT06716580

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.